FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005277623> ?p ?o ?g. }

• W2005277623 endingPage "1871" @default.
• W2005277623 startingPage "1869" @default.
• W2005277623 abstract "Future Medicinal ChemistryVol. 4, No. 15 Special Focus Issue: Computational Chemistry - EditorialNoticing the unnoticed: bridging structural data and drug designJosé S Duca & Rajeshri G KarkiJosé S Duca* Author for correspondenceComputer-Aided Drug Discovery, Global Discovery Chemistry, Novartis Institutes for BioMedical Research Inc, 100 Technology Square, Cambridge, MA 02139, USA. Search for more papers by this authorEmail the corresponding author at jose.duca@novartis.com & Rajeshri G KarkiComputer-Aided Drug Discovery, Global Discovery Chemistry, Novartis Institutes for BioMedical Research Inc, 100 Technology Square, Cambridge, MA 02139, USASearch for more papers by this authorPublished Online:22 Oct 2012https://doi.org/10.4155/fmc.12.163AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: crystal structuresintermolecular interactionsstructure-informed designReferences1 Berman HM, Westbrook J, Feng Z et al. The Protein Data Bank. Nucleic Acids Research28(1),235–242 (2000).Crossref, Medline, CAS, Google Scholar2 Huang X, Cheng CC, Fischmann TO et al. Discovery of a novel series of CHK1 kinase inhibitors with a distinctive hinge binding mode. ACS Med.Chem.Lett.3(2),123–128 (2012).Crossref, Medline, CAS, Google Scholar3 Lu YX, Liu YT, Xu ZJ, Li HY, Liu HL, Zhu WL. Halogen bonding for rational drug design and new drug discovery. Expert Opin. Drug Discov.7(5),375–383 (2012).Crossref, Medline, CAS, Google Scholar4 Erdelyi M. Halogen bonding in solution. Chem. Soc. Rev.41(9),3547–3557 (2012).Crossref, Medline, CAS, Google Scholar5 Fischmann TO, Hruza A, Duca JS et al. Structure-guided discovery of cyclin-dependent kinase inhibitors. Biopolymers89(5),372–379 (2008).Crossref, Medline, CAS, Google Scholar6 Grossman M, Sela-Passwell N, Sagi I. Achieving broad molecular insights into dynamic protein interactions by integrated structural-kinetic approaches. Cur. Opin. Struct. Bio.21(5),678–685 (2011).Crossref, Medline, CAS, Google Scholar7 Wong SE, Lightstone FC. Accounting for water molecules in drug design. Expert Opin. Drug Discov.6(1),65–74 (2010).Crossref, Medline, Google Scholar8 Young T, Abel R, Kim B, Berne BJ, Friesner RA. Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding. Proc. Natl Acad. Sci. USA104(3),808–813 (2007).Crossref, Medline, CAS, Google Scholar9 Robinson DD, Sherman W, Farid R. Understanding kinase selectivity through energetic analysis of binding site waters. ChemMedChem5(4),618–627 (2010).Crossref, Medline, CAS, Google Scholar10 Núñez S, Venhorst J, Kruse CG. Target-drug interactions: first principles and their application to drug discovery. Drug Discov. Today17(1–2),10–22 (2012).Crossref, Medline, CAS, Google Scholar11 Pearlstein RA, Hu QY, Zhou J et al. New hypotheses about the structure-function of proprotein convertase subtilisin/kexin type 9: analysis of the epidermal growth factor-like repeat A docking site using WaterMap. Proteins78(12),2571–2586 (2010).Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByAntibiotics: where to throw the spanner in the ribosomal machinery?Samuel A McKie21 September 2016 | Future Medicinal Chemistry, Vol. 8, No. 16 Vol. 4, No. 15 Follow us on social media for the latest updates Metrics Downloaded 301 times History Published online 22 October 2012 Published in print October 2012 Information© Future Science LtdKeywordscrystal structuresintermolecular interactionsstructure-informed designFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W2005277623 created "2016-06-24" @default.
• W2005277623 creator A5001778051 @default.
• W2005277623 creator A5085943341 @default.
• W2005277623 date "2012-10-01" @default.
• W2005277623 modified "2023-09-25" @default.
• W2005277623 title "Noticing the unnoticed: bridging structural data and drug design" @default.
• W2005277623 cites W1966534221 @default.
• W2005277623 cites W2004364785 @default.
• W2005277623 cites W2012500759 @default.
• W2005277623 cites W2018107830 @default.
• W2005277623 cites W2019436548 @default.
• W2005277623 cites W2056490854 @default.
• W2005277623 cites W2081719547 @default.
• W2005277623 cites W2130479394 @default.
• W2005277623 cites W2147542160 @default.
• W2005277623 cites W2166845515 @default.
• W2005277623 doi "https://doi.org/10.4155/fmc.12.163" @default.
• W2005277623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23088265" @default.
• W2005277623 hasPublicationYear "2012" @default.
• W2005277623 type Work @default.
• W2005277623 sameAs 2005277623 @default.
• W2005277623 citedByCount "1" @default.
• W2005277623 countsByYear W20052776232016 @default.
• W2005277623 crossrefType "journal-article" @default.
• W2005277623 hasAuthorship W2005277623A5001778051 @default.
• W2005277623 hasAuthorship W2005277623A5085943341 @default.
• W2005277623 hasConcept C161191863 @default.
• W2005277623 hasConcept C171250308 @default.
• W2005277623 hasConcept C185592680 @default.
• W2005277623 hasConcept C192562407 @default.
• W2005277623 hasConcept C2779473830 @default.
• W2005277623 hasConcept C41008148 @default.
• W2005277623 hasConcept C55493867 @default.
• W2005277623 hasConcept C60644358 @default.
• W2005277623 hasConcept C71924100 @default.
• W2005277623 hasConcept C74187038 @default.
• W2005277623 hasConcept C86803240 @default.
• W2005277623 hasConceptScore W2005277623C161191863 @default.
• W2005277623 hasConceptScore W2005277623C171250308 @default.
• W2005277623 hasConceptScore W2005277623C185592680 @default.
• W2005277623 hasConceptScore W2005277623C192562407 @default.
• W2005277623 hasConceptScore W2005277623C2779473830 @default.
• W2005277623 hasConceptScore W2005277623C41008148 @default.
• W2005277623 hasConceptScore W2005277623C55493867 @default.
• W2005277623 hasConceptScore W2005277623C60644358 @default.
• W2005277623 hasConceptScore W2005277623C71924100 @default.
• W2005277623 hasConceptScore W2005277623C74187038 @default.
• W2005277623 hasConceptScore W2005277623C86803240 @default.
• W2005277623 hasIssue "15" @default.
• W2005277623 hasLocation W20052776231 @default.
• W2005277623 hasLocation W20052776232 @default.
• W2005277623 hasOpenAccess W2005277623 @default.
• W2005277623 hasPrimaryLocation W20052776231 @default.
• W2005277623 hasRelatedWork W1546408466 @default.
• W2005277623 hasRelatedWork W1602625960 @default.
• W2005277623 hasRelatedWork W2028705520 @default.
• W2005277623 hasRelatedWork W2061639288 @default.
• W2005277623 hasRelatedWork W2079812848 @default.
• W2005277623 hasRelatedWork W2081303479 @default.
• W2005277623 hasRelatedWork W2748952813 @default.
• W2005277623 hasRelatedWork W2899084033 @default.
• W2005277623 hasRelatedWork W3044253523 @default.
• W2005277623 hasRelatedWork W2074340037 @default.
• W2005277623 hasVolume "4" @default.
• W2005277623 isParatext "false" @default.
• W2005277623 isRetracted "false" @default.
• W2005277623 magId "2005277623" @default.
• W2005277623 workType "article" @default.